-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Vistagen Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
- Vistagen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 30.6M shares, a 317% increase year-over-year.
- Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 19.4M shares, a 178% increase from 2022.
- Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.96M shares.
- Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2015 was 1.77M shares, a 34.1% increase from 2014.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)